Lin Hsia-Lien, Kent Ute M, Zhang Haoming, Waskell Lucy, Hollenberg Paul F
Department of Pharmacology, 2301 MSRB III, 1150 West Medical Center Drive, Ann Arbor, MI 48109-0632, USA.
J Pharmacol Exp Ther. 2004 Dec;311(3):855-63. doi: 10.1124/jpet.104.071670. Epub 2004 Aug 9.
We have previously demonstrated that substituting Val for Thr-205 in P450 2B1 abolishes the 16beta-hydroxylation of testosterone and markedly decreases the ability of 2-ethnylnaphthalene (2EN) and 17alpha-ethynylestradiol (17EE) to inactivate P450 2B1. The role of Thr-205 has been further investigated by measuring the kinetics of the mechanism-based inactivation of the 7-ethoxy-(trifluoromethyl)coumarin deethylation activity of 2B1 by 2EN and 17EE in wild-type (WT) and mutant P450s. In general, the kinetics of the inactivation of the Ser and Ala mutants was not significantly altered compared with WT. In contrast, the efficiency of the inactivation of the Val mutant decreased by approximately 6- and approximately 30-fold for 2EN and 17EE, respectively. High-pressure liquid chromatography (HPLC) analysis and SDS gel electrophoresis demonstrated the covalent binding of radiolabeled 2EN- and 17EE-reactive intermediates to the WT apoprotein, but not the Val mutant. The Val mutant was able to metabolize 2EN to 2-naphthylacetic acid, except the initial rate was slower than the WT. HPLC analysis of the 17EE incubation mixtures revealed three major metabolites and showed a correlation between the efficiency of inactivation and the generation of one of the major metabolites (C). Metabolite C was generated by the WT, Ser mutant, and Ala mutant. Metabolite C may be formed by the oxidation of the ethynyl group, and this reactive intermediate contributes to the inactivation of P450 2B1 by 17EE. The site-specific mutation of one residue, Thr-205 to Val, is sufficient to alter the profile of products formed during 17EE metabolism, such that very low levels of metabolite C are formed and inactivation is essentially abolished.
我们之前已经证明,在细胞色素P450 2B1中用缬氨酸替代苏氨酸-205可消除睾酮的16β-羟基化作用,并显著降低2-乙炔基萘(2EN)和17α-乙炔基雌二醇(17EE)使细胞色素P450 2B1失活的能力。通过测量野生型(WT)和突变型细胞色素P450中2EN和17EE对2B1的7-乙氧基-(三氟甲基)香豆素脱乙基化活性的基于机制的失活动力学,进一步研究了苏氨酸-205的作用。一般来说,与野生型相比,丝氨酸和丙氨酸突变体的失活动力学没有显著改变。相比之下,缬氨酸突变体的失活效率分别降低了约6倍和约30倍,2EN和17EE的失活效率分别降低了约6倍和约30倍。高压液相色谱(HPLC)分析和SDS凝胶电泳表明,放射性标记的2EN和17EE反应性中间体与野生型脱辅基蛋白发生共价结合,但与缬氨酸突变体没有发生共价结合。缬氨酸突变体能够将2EN代谢为2-萘乙酸,只是初始速率比野生型慢。对17EE孵育混合物的HPLC分析揭示了三种主要代谢产物,并显示失活效率与其中一种主要代谢产物(C)的生成之间存在相关性。代谢产物C由野生型、丝氨酸突变体和丙氨酸突变体生成。代谢产物C可能是由乙炔基氧化形成的,这种反应性中间体有助于17EE使细胞色素P450 2B1失活。一个残基苏氨酸-205突变为缬氨酸的位点特异性突变足以改变17EE代谢过程中形成的产物谱,使得代谢产物C的水平非常低,失活基本上被消除。